2015
$115M
from 12 investors over 12 rounds
Obsidian Therapeutics raised $115M on September 9, 2021
Investors: RA Capital Management, L.P., Logos Global Management, LP, Samsara BioCapital, Vertex Ventures HC, Surveyor Capital, Soleus Capital Management, L.P. and The Column Group
Obsidian Therapeutics raised $50M on December 6, 2017
Investors: GV, Takeda UK Limited, Atlas Venture, Vertex Ventures HC and shangpharm